Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Cardiomyopathy | Research

Identification of patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias: insights from cardiac magnetic resonance feature tracking

Authors: Hai-Yan Ma, Guang-You Xie, Jian Tao, Zong-Zhuang Li, Pan Liu, Xing-Ju Zheng, Rong-Pin Wang

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

Patients with nonischemic dilated cardiomyopathy (NIDCM) are prone to arrhythmias, and the cause of mortality in these patients is either end-organ dysfunction due to pump failure or malignant arrhythmia-related death. However, the identification of patients with NIDCM at risk of malignant ventricular arrhythmias (VAs) is challenging in clinical practice. The aim of this study was to evaluate whether cardiovascular magnetic resonance feature tracking (CMR-FT) could help in the identification of patients with NIDCM at risk of malignant VAs.

Methods

A total of 263 NIDCM patients who underwent CMR, 24-hour Holter electrocardiography (ECG) and inpatient ECG were retrospectively evaluated. The patients with NIDCM were allocated to two subgroups: NIDCM with VAs and NIDCM without VAs. From CMR-FT, the global peak radial strain (GPRS), global longitudinal strain (GPLS), and global peak circumferential strain (GPCS) were calculated from the left ventricle (LV) model. We investigated the possible predictors of NIDCM combined with VAs by univariate and multivariate logistic regression analyses.

Results

The percent LGE (15.51 ± 3.30 vs. 9.62 ± 2.18, P < 0.001) was higher in NIDCM patients with VAs than in NIDCM patients without VAs. Furthermore, the NIDCM patients complicated with VAs had significantly lower GPCS than the NIDCM patients without VAs (− 5.38 (− 7.50, − 4.22) vs.−9.22 (− 10.73, − 8.19), P < 0.01). Subgroup analysis based on LGE negativity showed that NIDCM patients complicated with VAs had significantly lower GPRS, GPCS, and GPLS than NIDCM patients without VAs (P < 0.05 for all). Multivariate analysis showed that both GPCS and %LGE were independent predictors of NIDCM combined with VAs.

Conclusions

CMR global strain can be used to identify NIDCM patients complicated with VAs early, specifically when LGE is not present. GPCS < − 13.19% and %LGE > 10.37% are independent predictors of NIDCM combined with VAs.
Literature
1.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, ESC Scientific Document Group, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic Heart Failure. Eur Heart J. 2016;37:2129–200.CrossRefPubMed Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, ESC Scientific Document Group, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic Heart Failure. Eur Heart J. 2016;37:2129–200.CrossRefPubMed
3.
go back to reference Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013;6(9):944–54.CrossRefPubMedPubMedCentral Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, et al. CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2013;6(9):944–54.CrossRefPubMedPubMedCentral
4.
go back to reference Poyhonen P, Kivisto S, Holmstrom M, Hanninen H. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study. BMC Cardiovasc Disord. 2014(1);14:110. Poyhonen P, Kivisto S, Holmstrom M, Hanninen H. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study. BMC Cardiovasc Disord. 2014(1);14:110.
5.
go back to reference Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, et al. Association between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135(1):2106–15.CrossRefPubMedPubMedCentral Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, et al. Association between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135(1):2106–15.CrossRefPubMedPubMedCentral
6.
go back to reference Yamada T, Hirashiki A, Okumura T, Adachi S, Shimazu S, Shimizu S, et al. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy. J Card Fail. 2014;20(11):825–32.CrossRefPubMed Yamada T, Hirashiki A, Okumura T, Adachi S, Shimazu S, Shimizu S, et al. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy. J Card Fail. 2014;20(11):825–32.CrossRefPubMed
7.
go back to reference Piers SR, Everaerts K, van der Geest RJ, Hazebroek MR, Siebelink HM, Pison LA, et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm. 2015;12(10):2106–14.CrossRefPubMed Piers SR, Everaerts K, van der Geest RJ, Hazebroek MR, Siebelink HM, Pison LA, et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm. 2015;12(10):2106–14.CrossRefPubMed
8.
go back to reference Strohm O, Schulz-Menger J, Pilz B, Osterziel KJ, Dietz R, Friedrich MG. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging. 2001;13(3):367–71.CrossRefPubMed Strohm O, Schulz-Menger J, Pilz B, Osterziel KJ, Dietz R, Friedrich MG. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging. 2001;13(3):367–71.CrossRefPubMed
9.
go back to reference Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67(25):2996–3010.CrossRefPubMed Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67(25):2996–3010.CrossRefPubMed
10.
go back to reference Porcari A, De Angelis G, Romani S, Paldino A, Artico J, Cannata A, et al. Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques. Expert Rev Cardiovasc Ther. 2019;17(1):53–63.CrossRefPubMed Porcari A, De Angelis G, Romani S, Paldino A, Artico J, Cannata A, et al. Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques. Expert Rev Cardiovasc Ther. 2019;17(1):53–63.CrossRefPubMed
11.
go back to reference Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging. 2016;9(4):e004077.CrossRefPubMed Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging. 2016;9(4):e004077.CrossRefPubMed
12.
go back to reference Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E. Tissue Tracking Technology for assessing Cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging. 2015;8(12):1444–60.CrossRefPubMed Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E. Tissue Tracking Technology for assessing Cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging. 2015;8(12):1444–60.CrossRefPubMed
13.
go back to reference Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with Heart Failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34.CrossRefPubMed Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with Heart Failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34.CrossRefPubMed
14.
go back to reference Obokata M, Nagata Y, Wu VC, Kado Y, Kurabayashi M, Otsuji Y, et al. Direct comparison of cardiac magnetic resonance feature tracking and 2D/3D echocardiography speckle tracking for evaluation of global left ventricular strain. Eur Heart J Cardiovasc Imaging. 2016;17(5):525–32.CrossRefPubMed Obokata M, Nagata Y, Wu VC, Kado Y, Kurabayashi M, Otsuji Y, et al. Direct comparison of cardiac magnetic resonance feature tracking and 2D/3D echocardiography speckle tracking for evaluation of global left ventricular strain. Eur Heart J Cardiovasc Imaging. 2016;17(5):525–32.CrossRefPubMed
15.
go back to reference Linsheng Song X, Zhao. Wenlong Lv,Jie Zeng,Yishuang Wang, Bo Gong, preliminary study on the diagnostic value of cardiac magnetic resonance feature tracking for malignant ventricular arrhythmias in non-ischemic dilated cardiomyopathy. Ann Transl Med. 2022;10(4):1–11. Linsheng Song X, Zhao. Wenlong Lv,Jie Zeng,Yishuang Wang, Bo Gong, preliminary study on the diagnostic value of cardiac magnetic resonance feature tracking for malignant ventricular arrhythmias in non-ischemic dilated cardiomyopathy. Ann Transl Med. 2022;10(4):1–11.
16.
go back to reference Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial Diseases. Eur Heart J. 2016;37(23):1850–8.CrossRefPubMed Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial Diseases. Eur Heart J. 2016;37(23):1850–8.CrossRefPubMed
17.
go back to reference Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17.CrossRefPubMedPubMedCentral Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17.CrossRefPubMedPubMedCentral
18.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, American Heart Association Writing Group on, Myocardial S, et al. Registration for Cardiac I. standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(2):539–42.PubMed Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, American Heart Association Writing Group on, Myocardial S, et al. Registration for Cardiac I. standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(2):539–42.PubMed
19.
go back to reference Brachmann J, Hilbel T, Grunig E, Benz A, Haass M, Kubler W. Ventricular arrhythmias in dilated cardiomyopathy. Pacing Clin Electrophysiol. 1997;20(2):2714–8.CrossRefPubMed Brachmann J, Hilbel T, Grunig E, Benz A, Haass M, Kubler W. Ventricular arrhythmias in dilated cardiomyopathy. Pacing Clin Electrophysiol. 1997;20(2):2714–8.CrossRefPubMed
20.
go back to reference Di Marco A, Anguera I, Schmitt M, Klem I, Neilan TG, White JA, et al. Late Gadolinium Enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and Meta-analysis. JACC Heart Fail. 2017;5(1):28–38.CrossRefPubMed Di Marco A, Anguera I, Schmitt M, Klem I, Neilan TG, White JA, et al. Late Gadolinium Enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and Meta-analysis. JACC Heart Fail. 2017;5(1):28–38.CrossRefPubMed
21.
go back to reference Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977–85.CrossRefPubMed Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977–85.CrossRefPubMed
22.
go back to reference Masci PG, Barison A, Aquaro GD, Pingitore A, Mariotti R, Balbarini A, et al. Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. Int J Cardiol. 2012;157(1):43–7.CrossRefPubMed Masci PG, Barison A, Aquaro GD, Pingitore A, Mariotti R, Balbarini A, et al. Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. Int J Cardiol. 2012;157(1):43–7.CrossRefPubMed
23.
go back to reference Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51(25):2414–21.CrossRefPubMedPubMedCentral Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51(25):2414–21.CrossRefPubMedPubMedCentral
24.
go back to reference Perazzolo Marra M, De Lazzari M, Zorzi A, Migliore F, Zilio F, Calore C, et al. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and Sudden Cardiac Death in nonischemic dilated cardiomyopathy. Heart Rhythm. 2014;11(5):856–63.CrossRefPubMed Perazzolo Marra M, De Lazzari M, Zorzi A, Migliore F, Zilio F, Calore C, et al. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and Sudden Cardiac Death in nonischemic dilated cardiomyopathy. Heart Rhythm. 2014;11(5):856–63.CrossRefPubMed
25.
go back to reference Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late Gadolinium Enhancement. JACC Cardiovasc Imaging. 2019;12(2):1645–55.CrossRefPubMedPubMedCentral Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late Gadolinium Enhancement. JACC Cardiovasc Imaging. 2019;12(2):1645–55.CrossRefPubMedPubMedCentral
26.
go back to reference Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging. 2012;5(4):448–56.CrossRefPubMed Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging. 2012;5(4):448–56.CrossRefPubMed
27.
go back to reference Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and Sudden Cardiac Death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896–908.CrossRefPubMed Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and Sudden Cardiac Death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896–908.CrossRefPubMed
28.
go back to reference Perez-David E, Arenal A, Rubio-Guivernau JL, Del Castillo R, Leonardo Atea E, Arbelo, et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic Myocardial Infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol. 2011;57(2):184–94.CrossRefPubMed Perez-David E, Arenal A, Rubio-Guivernau JL, Del Castillo R, Leonardo Atea E, Arbelo, et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic Myocardial Infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol. 2011;57(2):184–94.CrossRefPubMed
29.
go back to reference Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced Cardiac Arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006–14.CrossRefPubMedPubMedCentral Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced Cardiac Arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006–14.CrossRefPubMedPubMedCentral
30.
go back to reference Disertori M, Quintarelli S, Mazzola S, Favalli V, Narula N, Arbustini E. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Europace. 2013;15(12):1693–701.CrossRefPubMed Disertori M, Quintarelli S, Mazzola S, Favalli V, Narula N, Arbustini E. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Europace. 2013;15(12):1693–701.CrossRefPubMed
31.
go back to reference McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of Heart Failure related to dilated cardiomyopathy and coronary artery Disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108(1):54–9.CrossRefPubMed McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of Heart Failure related to dilated cardiomyopathy and coronary artery Disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108(1):54–9.CrossRefPubMed
32.
go back to reference De Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int. 2001;14(5):299–306.CrossRefPubMed De Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int. 2001;14(5):299–306.CrossRefPubMed
33.
go back to reference Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 1995;27(1):291–305.CrossRefPubMed Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 1995;27(1):291–305.CrossRefPubMed
34.
go back to reference Waller TA, Hiser WL, Capehart JE, Roberts WC. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol. 1998;81(1):884–94.CrossRefPubMed Waller TA, Hiser WL, Capehart JE, Roberts WC. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol. 1998;81(1):884–94.CrossRefPubMed
35.
go back to reference Schuster A, Morton G, Hussain ST, Jogiya R, Kutty S, Asrress KN, et al. The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is Independent of field strength. Eur J Radiol. 2013;82(2):296–301.CrossRefPubMed Schuster A, Morton G, Hussain ST, Jogiya R, Kutty S, Asrress KN, et al. The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is Independent of field strength. Eur J Radiol. 2013;82(2):296–301.CrossRefPubMed
36.
go back to reference Schuster A, Stahnke VC, Unterberg-Buchwald C, Kowallick JT, Lamata P, Steinmetz M, et al. Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics: Intervendor agreement and considerations regarding reproducibility. Clin Radiol. 2015;70(9):989–98.CrossRefPubMedPubMedCentral Schuster A, Stahnke VC, Unterberg-Buchwald C, Kowallick JT, Lamata P, Steinmetz M, et al. Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics: Intervendor agreement and considerations regarding reproducibility. Clin Radiol. 2015;70(9):989–98.CrossRefPubMedPubMedCentral
37.
go back to reference Yang-Yang Qu JP, Li H, Ma G-S, Buckert D, Rasche V. Left ventricular myocardial strain quantification with two-and three-dimensional cardiovascular magnetic resonance based tissue tracking. Quant Imaging Med Surg. 2021;11(4):1421–36.CrossRefPubMedPubMedCentral Yang-Yang Qu JP, Li H, Ma G-S, Buckert D, Rasche V. Left ventricular myocardial strain quantification with two-and three-dimensional cardiovascular magnetic resonance based tissue tracking. Quant Imaging Med Surg. 2021;11(4):1421–36.CrossRefPubMedPubMedCentral
Metadata
Title
Identification of patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias: insights from cardiac magnetic resonance feature tracking
Authors
Hai-Yan Ma
Guang-You Xie
Jian Tao
Zong-Zhuang Li
Pan Liu
Xing-Ju Zheng
Rong-Pin Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-023-03655-4

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue